Catalyst Wire Dossier Catalyst Wire Dossier

Brivanib alaninate

brivanib alaninate · Bristol-Myers Squibb
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Brivanib alaninate, covering 2015-07-07 to 2017-11-06. Get the full timeline:

Most recent: Clinical Trial Update: Brivanib Alaninate in Treating Patients With Recurrent or Persistent Endometrial Cancer [Phase 2]

See pricing